216 related articles for article (PubMed ID: 6334720)
1. Immunomodulation and antitumor effects of MVE-2 in mice.
Talmadge JE; Maluish AE; Collins M; Schneider M; Herberman RB; Oldham RK; Wiltrout RH
J Biol Response Mod; 1984 Dec; 3(6):634-52. PubMed ID: 6334720
[TBL] [Abstract][Full Text] [Related]
2. Inability of anti-asialo-GM1 and 2-chloroadenosine to abrogate maleic anhydride-divinyl ether-induced resistance against experimental murine lung carcinoma metastases.
Schultz RM; Tang JC; DeLong DC; Ades EW; Altom MG
Cancer Res; 1986 Nov; 46(11):5624-8. PubMed ID: 3756909
[TBL] [Abstract][Full Text] [Related]
3. Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver.
Wiltrout RH; Herberman RB; Zhang SR; Chirigos MA; Ortaldo JR; Green KM; Talmadge JE
J Immunol; 1985 Jun; 134(6):4267-75. PubMed ID: 3989307
[TBL] [Abstract][Full Text] [Related]
4. In vivo modulation of myelopoiesis and immune functions by maleic anhydride divinyl ether copolymer (MVE-2) in tumor-free and MBL-2 tumor-bearing mice treated with cyclophosphamide.
Schlick E; Ruffmann R; Chirigos MA; Welker RD; Herberman RB
Cancer Res; 1985 Mar; 45(3):1108-14. PubMed ID: 3871661
[TBL] [Abstract][Full Text] [Related]
5. Maleic vinyl ether activation of murine macrophages against lung-metastasizing tumors.
Loveless SE; Munson AE
Cancer Res; 1981 Oct; 41(10):3901-6. PubMed ID: 7285000
[TBL] [Abstract][Full Text] [Related]
6. Therapy of artificial and spontaneous metastases of murine tumors with maleic anhydride-divinyl ether-2.
Milas L; Hersh EM; Hunter N
Cancer Res; 1981 Jun; 41(6):2378-85. PubMed ID: 7237436
[TBL] [Abstract][Full Text] [Related]
7. Augmentation of mouse liver-associated natural killer activity by biologic response modifiers occurs largely via rapid recruitment of large granular lymphocytes from the bone marrow.
Wiltrout RH; Pilaro AM; Gruys ME; Talmadge JE; Longo DL; Ortaldo JR; Reynolds CW
J Immunol; 1989 Jul; 143(1):372-8. PubMed ID: 2732472
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemoimmunotherapy of cancer: influence of tumor burden and role of functional immune effector cells in mice.
Schlick E; Hewetson P; Ruffmann R
Cancer Res; 1986 Jul; 46(7):3378-83. PubMed ID: 3708572
[TBL] [Abstract][Full Text] [Related]
9. Pyran (MVE-5) reverses the inhibition of macrophage receptors for cytophilic antibody induced by soluble immune complexes.
Rao VS; Mitchell MS
J Biol Response Mod; 1983; 2(1):67-80. PubMed ID: 6606020
[TBL] [Abstract][Full Text] [Related]
10. Regulation of natural killer cell activation: implementation for the control of tumor metastasis.
Hanna N
Nat Immun Cell Growth Regul; 1983-1984; 3(1):22-33. PubMed ID: 6235447
[TBL] [Abstract][Full Text] [Related]
11. Immunomodulatory effect of various molecular-weight maleic anhydride-divinyl ethers and other agents in vivo.
Chirigos MA; Stylos WA
Cancer Res; 1980 Jun; 40(6):1967-72. PubMed ID: 7371032
[TBL] [Abstract][Full Text] [Related]
12. Biological response modifiers: regulators of the cellular immune system and adjuvants in antitumor therapy.
Chirigos MA; Schlick E; Saito T; Gruys E
Methods Find Exp Clin Pharmacol; 1986 Jan; 8(1):27-33. PubMed ID: 3486334
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the immunological and toxicological properties of MVE-2 in phase I trials.
Rinehart JJ; Young DC; Neidhart JA
Cancer Res; 1983 May; 43(5):2358-62. PubMed ID: 6831459
[TBL] [Abstract][Full Text] [Related]
14. Relationship of molecular weight to antiviral and antitumor activities and toxic effects of maleic anhydride-divinyl ether (MVE) polyanions.
Morahan PS; Barnes DW; Munson AE
Cancer Treat Rep; 1978 Nov; 62(11):1797-803. PubMed ID: 103618
[TBL] [Abstract][Full Text] [Related]
15. Induction of natural killer cell activity in mice by injection of indomethacin.
Voth R; Chmielarczyk W; Storch E; Kirchner H
Nat Immun Cell Growth Regul; 1986; 5(6):317-24. PubMed ID: 2432415
[TBL] [Abstract][Full Text] [Related]
16. Expansion of natural killer cells in mice transgenic for IgM antibody to ganglioside GD2: demonstration of prolonged survival after challenge with syngeneic tumor cells.
Kawashima I; Yoshida Y; Taya C; Shitara H; Yonekawa H; Karasuyama H; Tada N; Furukawa K; Tai T
Int J Oncol; 2003 Aug; 23(2):381-8. PubMed ID: 12851687
[TBL] [Abstract][Full Text] [Related]
17. Antileukemia activity of a natural killer cell line against human leukemias.
Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
[TBL] [Abstract][Full Text] [Related]
18. Response of murine leukemia to combined BCNU-maleic anhydride-vinyl ether (MVE) adjuvant therapy and correlation with macrophage activation by MVE in the in vitro growth inhibition assay.
Dean JH; Padarathsingh ML; Keys L
Cancer Treat Rep; 1978 Nov; 62(11):1807-16. PubMed ID: 728898
[No Abstract] [Full Text] [Related]
19. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
20. Rapid killing of actinomycin D-treated tumor cells by human mononuclear cells. I. Effectors belong to the monocyte-macrophage lineage.
Colotta F; Peri G; Villa A; Mantovani A
J Immunol; 1984 Feb; 132(2):936-44. PubMed ID: 6690624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
